MVF – Macquarie rates the stock as Outperform

Macquarie raises FY22-4 EPS forecasts by 2% for Monash IVF Group following a 1Q trading update and 1H22 profit guidance which was a 5% beat versus the broker’s forecast. The target price lifts to $1.15 from $1.10.

Australian fresh cycles growth in the 1Q implies to the analyst share gains of around 190 basis points. The Outperform rating is maintained.

Sector: Pharmaceuticals, Biotechnology & Life Sciences.


Target price is $1.10.Current Price is $0.98. Difference: $0.12 – (brackets indicate current price is over target). If MVF meets the Macquarie target it will return approximately 11% (excluding dividends, fees and charges – negative figures indicate an expected loss).



About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →